Scientific advancements will offer mankind choices as advancements can be used for both good and bad. So you would proposed halting innovation and moving forward as a society because somebody may use technology for something YOU believe is morally wrong? We should not have inventing aircraft because they can be used for war? We should not have any pain reducing reducing medications because some people can abuse them, right? Take your money and invest in a bible store or something morally safe. We don't need your money or your primitive thinking.
The stock must drop to account for the dividend earned today. So $0.41 of the drop today is just the dividend earned today. You'll get it back when it hits your account March 2nd.
Let's squeeze the shorts until they have margin calls and are forced to sell other holding to buy UAN at a huge loss. It is what all those stock manipulators deserve trying to make money off their unethical ways.
Let's squeeze the shorts until they have margin calls and are forced to sell other holding to buy TRN at a huge loss. It is what all those stock manipulators deserve trying to make money off their unethical ways.
I bought my shares 2 years ago at $11.30 abd $11.70 and have picked up almost 400 shares since then re-investing dividends giving me a total of 5000 shares. I would love to see the stock soar with the Brazilian expansion and then possibly taken over by one of the major testing lab companies. Their patented hair follicle drug testing is faster and cheaper than anything on the market.
Been collecting a very nice 4% dividend for several years and watched this stock go from $12 to $16. Soon, the expansion in Brazil will start adding additional cash and profits to this company's bottom line and then it will be a buy at $20.
AbbVie Inc. (NYSE: ABBV) was started as Sell at Citigroup.
Read more: Top Analyst Upgrades and Downgrades: AbbVie, Alcoa, Apple, Deckers, Dish, Pfizer, Petrobras and More - Alcoa, Inc. (NYSE:AA) - 24/7 Wall St. http://247wallst.com/investing/2015/02/09/top-analyst-upgrades-and-downgrades-abbvie-alcoa-apple-deckers-dish-pfizer-petrobras-and-more/#ixzz3RIb2WA4i
Follow us: @247wallst on Twitter | 247wallst on Facebook
The Federal Highway Administration said on Friday that maybe there isn't a problem with Trinity end terminals. The agency had ordered a new round of eight crash tests in the wake of the humongous Texas fraud verdict. Data from the first four of those, assessing 27¾-inch rails, by far the most common variety, show that the Trinity gear "meets the applicable crash test criteria," the FHWA said in a prepared statement. The agency has more testing to do before giving Trinity a clean report card. But the preliminary results don't suggest a scourge of killer guardrails.
Texas A&M Transportation Institute, which designed the technology Trinity uses, released a separate statement calling the ET-Plus "a safe, effective roadside safety product." Referring to all eight federally mandated tests, the latter four of which the government hasn't yet formally analyzed, the university research arm said: "It should be especially noted that in each of the eight tests, no guardrail speared the cabin of the vehicle, nor did any vehicle roll over—two key measures in determining success in such testing."
Trinity itself issued a muted press release reiterating its contention that "when installed, maintained, and impacted within" relevant standards, the ET-Plus functions as required.